Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a minor software update to the underlying system. This is a technical version bump and does not change the clinical trial details or visible content.
    Difference
    0.1%
    Check dated 2026-07-28T10:53:08.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.3, indicating a minor update to the document history. The change reflects a version bump rather than a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-06-30T00:42:13.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows a recruitment status, and adds guidance sections for reading the study record and joining the study. The Interventions/Treatment label is reformatted and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T18:57:16.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a minor version update to the page's documentation/markup rather than substantive study information.
    Difference
    0.1%
    Check dated 2026-06-08T16:22:21.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    New revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects an update to the page’s release/version labeling rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-18T03:49:57.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    The page revision marker was updated from v3.5.0 to v3.5.3, reflecting a maintenance/version update rather than a change to any clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-26T15:17:32.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.